CD8A and neoplasm: To investigate alterations in the tumor microenvironment (TME) before and after neoadjuvant ensartinib treatment, multiplex fluorescence staining was performed on pre-neoadjuvant and postoperative samples, with a focus on CD8+ T cells, macrophages, PD-1, and PD-L1 (Figure 3).